February 4th, 2022
Podcast 281: Drug Costs — What’s “The Right Price” for prescription pharmaceuticals?
Why can’t the U.S. control prescription drug pricing as they do in the U.K., where per-capita spending is less than half our level? In a capitalist democracy, many parties — the drug companies, medical associations, consumer groups — get to lobby their points of view. Is the problem intractable, or just an exercise in chaos? Our three […]
June 3rd, 2015
Podcast 175: “Understanding Value-Based Healthcare” — A Discussion with the Authors of an Important New Book
Running time: 26 minutes “Understanding Value-Based Healthcare,” published in April by McGraw-Hill is today’s focus. Drs. Christopher Moriates, of the University of California, San Francisco; Vineet Arora, of the University of Chicago; and Neel Shah of Harvard Medical — the book’s authors — discuss its straightforward approach to valuing patient outcomes foremost. The discussion ranges over their reasons […]
August 3rd, 2011
Podcast 127: Why QALYs matter
This time we talk with Dr. Katia Noyes, first author on a study of the cost-effectiveness of disease-modifying drugs in multiple sclerosis. If you don’t treat MS, don’t think that the topic is irrelevant. Noyes brings the issues of cost-effectiveness and the dreaded QALY into focus for clinicians who see patients. After all, medical costs will […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
